Israel vs United Arab Emirates: HIV-positive TB patients on ART (antiretroviral therapy)
Israel
100.0%
in 2024
United Arab Emirates
100.0%
in 2024
Israel rank
1st
United Arab Emirates rank
1st
HIV-positive TB patients on ART (antiretroviral therapy) over time
- Israel
- United Arab Emirates
How they compare
Israel currently reports 100.0% against 100.0% in United Arab Emirates, a difference of 0.0%.
Across all 9 years both countries report, United Arab Emirates has been ahead every year.
Israel ranks 1st and United Arab Emirates ranks 1st of 144 countries.
United Arab Emirates has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Israel | United Arab Emirates | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 100.0% | 100.0% | 0.0% | — |
| 2020s | 98.2% | 100.0% | 1.8% | United Arab Emirates |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv-positive tb patients on art (antiretroviral therapy), Israel or United Arab Emirates?
- Israel, at 100.0% against 100.0% in United Arab Emirates as of 2024.
- What is the difference in hiv-positive tb patients on art (antiretroviral therapy) between Israel and United Arab Emirates?
- 0.0%, with Israel ahead.
- How many years of comparable data are there for Israel and United Arab Emirates?
- 9 years are reported by both, from 2015 to 2024.
- How do Israel and United Arab Emirates rank globally for hiv-positive tb patients on art (antiretroviral therapy)?
- Israel ranks 1st and United Arab Emirates ranks 1st of 144 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as HIV-positive TB patients on ART (antiretroviral therapy) (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.